Verrucous carcinoma of the head and neck - not a human papillomavirus-related tumour?

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 4, 2014, Pages 635-645

  Odar, Katarina ^a   Kocjan, Boštjan J ^a   Hošnjak, Lea ^a   Gale, Nina ^a   Poljak, Mario ^a   Zidar, Nina ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Head and neck; Human papillomaviruses; P16 protein; Polymerase chain reaction; Verrucous carcinoma

Indexed keywords

P16 PROTEIN, HUMAN; TUMOR PROTEIN; VIRUS DNA;

ADULT; AGED; BIOSYNTHESIS; CLASSIFICATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; VERRUCOUS CARCINOMA; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, VERRUCOUS; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84897963890     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12211     Document Type: Article

References (45)

1. de Villiers EM. Cross-roads in the classification of papillomaviruses. Virology. 2013; 445: 2-10.
2. Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30S: F55-70.
3. El-Mofty SK. HPV-related squamous cell carcinoma variants in the head and neck. Head Neck Pathol. 2012; 6: S55-62.
4. Cardesa A, Zidar N. Verrucous carcinoma. Hypopharynx, larynx and trachea. In: Barnes L, Everson JW, Reichart PA, Sidransky D, editors. Pathology and genetics of tumours of the head and neck. WHO classification of tumours. Lyon: IARC; 2005. pp. 122-3.
5. Odar K, Zidar N, Bonin S, et al. Desmosomes in verrucous carcinoma of the head and neck. Histol Histopathol. 2012; 27: 467-74.
6. Odar K, Boštjančič E, Gale N, et al. Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck. Histopathol. 2012; 61: 257-65.
7. Szentimary Z, Pólus K, Tamás L, et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev. 2005; 24: 19-34.
8. Torrente MC, Rodrigo JP, Haigentz M, et al. Human papillomavirus infections in laryngeal cancer. Head Neck. 2011; 33: 581-6.
9. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol. 2001; 91: 622-34.
10. Abramson AL, Brandsma J, Steinberg B, et al. Verrucous carcinoma of the larynx. Arch Otolaryngol. 1985; 111: 709-15.
11. Adler-Storthz K, Newland JR, Tessin BA, et al. Human papillomavirus type 2 DNA in oral verrucous carcinoma. J Oral Pathol. 1986; 15: 472-5.
12. Greer RO Jr, Eversole LR, Crosby LK. Detection of human papillomavirus-genomic DNA in oral epithelial dysplasias, oral smokeless tobacco-associated leukoplakias, and epithelial malignancies. J Oral Maxillofac Surg. 1990; 48: 1201-5.
13. Perez-Ayala M, Ruiz-Cabello F, Esteban F, et al. Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer. 1990; 46: 8-11.
14. Johnson TL, Plieth DA, Crissman JD, et al. HPV detection by polymerase chain reaction (PCR) in verrucous lesions of the upper aerodigestive tract. Mod Pathol. 1991; 4: 461-5.
15. Young SK, Min KW. In situ DNA hybridization analysis of oral papillomas, leukoplakias, and carcinomas for human papillomavirus. Oral Surg Oral Med Oral Pathol. 1991; 71: 726-9.
16. Holladay EB, Gerald WL. Viral gene detection in oral neoplasms using polymerase chain reaction. Am J Clin Pathol. 1993; 100: 36-40.
17. Kasperbauer JL, O'Halloran GL, Espy MJ, et al. Polymerase chain reaction (PCR) identification of human papillomavirus (HPV) DNA in verrucous carcinoma of the larynx. Laryngoscope. 1993; 103: 416-20.
18. Noble-Topham SE, Fliss DM, Hartwick RW, et al. Detection and typing of human papillomavirus in verrucous carcinoma of the oral cavity using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg. 1993; 119: 1299-304.
19. Shroyer KR, Greer RO, Fankhouser CA, et al. Detection of human papillomavirus DNA in oral verrucous carcinoma by polymerase chain reaction. Mod Pathol. 1993; 6: 669-72.
20. Andersson JA, Irish JC, McLachlin CM, et al. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg. 1994; 120: 755-9.
21. Fliss DM, Noble-Topham SE, McLachlin M, et al. Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope. 1994; 104: 146-52.
22. Multhaupt HA, Fessler JN, Warhol MJ. Detection of human papillomavirus in laryngeal lesions by in situ hybridization. Hum Pathol. 1994; 25: 1302-5.
23. Balaram P, Nalinakumari KR, Abraham E, et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers-high prevalence and multiplicity of infections. Int J Cancer. 1995; 61: 450-4.
24. Lopez-Amado M, Garcia-Caballero T, Lozano-Ramirez A, et al. Human papillomavirus and p53 in verrucous carcinoma of the larynx. J Laryngol Otol. 1996; 110: 742-7.
25. Orvidas LJ, Lewis JE, Olsen KD, et al. Intranasal verrucous carcinoma: relationship to inverting papilloma and human papillomavirus. Laryngoscope. 1999; 109: 371-5.
26. Mitsuishi T, Ohara K, Kawashima M, et al. Prevalence of human papillomavirus DNA sequence in verrucous carcinoma of the lip: genomic and therapeutic approach. Cancer Lett. 2005; 222: 139-43.
27. Gonzalez JV, Gutierrez RA, Keszler A, et al. Human papillomavirus in oral lesions. Medicina (B Aires). 2007; 67: 363-8.
28. Fujita S, Senba M, Kumatori A, et al. Human papillomavirus in oral verrucous carcinoma: genotyping analysis and inverse correlation with p53 expression. Pathobiology. 2008; 75: 257-64.
29. Lin H-P, Wang Y-P, Chiang C-P. Expression of p53, MDM2, p21, heat shock protein 70, and HPV 16/18 E6 proteins in oral verrucous carcinoma and oral verrucous hyperplasia. Head Neck. 2011; 33: 334-40.
30. Saghravanian N, Ghazvini K, Babakoohi S, et al. Low prevalence of high-risk genotypes of human papillomavirus in normal oral mucosa, oral leukoplakia and verrucous carcinoma. Acta Odontol Scand. 2011; 69: 406-9.
31. Del Pino M, Bleeker MCG, Quint WG, et al. Comprehensive analysis of human papillomavirus prevalence and the potential role of low-risk types in verrucous carcinoma. Mod Pathol. 2012; 25: 1354-63.
32. Kocjan BJ, Seme K, Poljak M. Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens. J Virol Methods. 2011; 175: 117-9.
33. Komloš KF, Kocjan BJ, Košorok P, et al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol. 2012; 84: 1233-41.
34. Evans MF, Adamson CS, Simmons-Arnold L, et al. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol. 2005; 5: 10.
35. Kansky AA, Poljak M, Seme K, et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa. Acta Virol. 2003; 47: 11-6.
36. Kocjan BJ, Poljak M, Seme K, et al. Distribution of human papillomavirus genotypes in plucked eyebrow hairs from Slovenian males with genital warts. Infect Genet Evol. 2005; 5: 255-9.
37. Nazarenko I, Kobayashi L, Giles J, et al. A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP. J Virol Methods. 2008; 154: 76-81.
38. Harwood CA, Spink PJ, Surentheran T, et al. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol. 1999; 37: 3545-55.
39. Sasagawa T, Mitsuishi T. Novel polymerase chain reaction method for detecting cutaneous human papillomavirus DNA. J Med Virol. 2012; 84: 138-44.
40. Lewis JS Jr, Chernock RD, Ma X-J, et al. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status. Mod Pathol. 2012; 25: 1212-20.
41. Chernock RD, Wang X, Gao G, et al. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol. 2013; 26: 223-31.
42. Saito T, Nakajama T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med. 1999; 28: 226-32.
43. Antonsson A, Erfurt C, Hazard K, et al. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol. 2003; 84: 1881-6.
44. Botallico D, Chen Z, Dunne A, et al. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapilomavirus genera. J Infect Dis. 2011; 204: 787-92.
45. Patel KR, Chernock RD, Zhang TR, et al. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus. Hum Pathol. 2013; 44: 2385-92.